Week In Review: China's Luxin Invests In $215 Million Funding For Intarcia's Long-Term Diabetes …
Week In Review: China’s Luxin Invests In 5 Million Funding For Intarcia’s Long-Term Diabetes … Deals and Financings Luxin Venture Capital (SHA: 600783) of Shandong Pr…
